← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2015Last known activity
Sep 1, 2022
Timeline
1890s
- Jan 1, 1895
University of Texas, Arlington— Founded
Drugs by trial phase (22 distinct, 11 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (14 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (23)
- NCT06318377Sponsor investigatorN/ASep 1, 2022
- NCT06318377OfficialN/ASep 1, 2022
- NCT06318377Lead sponsorN/ASep 1, 2022
- NCT03684213Reponsible party - principal investigatorPhase 1Oct 15, 2018
- NCT03684213Lead sponsorPhase 1Oct 15, 2018
- NCT03680404Reponsible party - principal investigatorPhase 1Oct 1, 2018
- NCT03679780Reponsible party - principal investigatorPhase 1Oct 1, 2018
- NCT03680404Lead sponsorPhase 1Oct 1, 2018
- NCT03679780Lead sponsorPhase 1Oct 1, 2018
- NCT04671966Lead sponsorPhase 4Sep 13, 2018
- NCT04671966Overall official - principal investigatorPhase 4Sep 13, 2018
- NCT04907838CollaboratorN/AMay 1, 2018
- NCT03471117Lead sponsorPhase 4Apr 1, 2018
- NCT03471117Overall official - principal investigatorPhase 4Apr 1, 2018
- NCT03471117Reponsible party - principal investigatorPhase 4Apr 1, 2018
Details
- Founded
- Arlington, TX, US Jan 1, 1895
- Last known activity
- Sep 1, 2022